4Ma SY,Au WY,Chim CS,et al,Fludarabine,mitoxantrone and dexame thasone in the treatment of indolent B-and T-cell lymphoid malignancies in Chinese patients[J].Br J Haematol,2004,124(6):754.
5Mclaughlin P,Fredrick BH,Jorge ER,et a1.Fludarabine,mitoxantrone,and dexame thasone:an effective new regimen for indolent 1ymphoma[J].J Clin Oncol,1996,14(4):1262.
5Tallman MS, Hakimian D. Putine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood, 1995,86(7):2463-2474.
6Redman JR, Cahanillas F, Velaguez WS, et al. Phase Ⅱ trial of fludarabine phosphate in lymphoma: an effective new agent in lowgrade lymphoma.J Clin Oncol, 1992,10:790 -794.
7Velasquez WS, Lew D, Grogan TM, et al. Combination of Fludarabine and Mitoxantrone in Untreated Stages Ⅲ and Ⅳ low grade lymphoma:S9501. J Clin Oncol,2003,21(10): 1996-2003.
8Tam S,Wolf M,Januszewilz E,et al. A new model for predicting infections complications during fludarabine- based combination chemotherapy among patients with indolent lymphoid malignancies.Cancer, 2004,101(9): 2042-2049.
9Mclaughlin P, Fredrick BH, Jorge ER, et el. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. J Clin Oncol, 1996,14(4): 1262-1268.
10Lynch JW, Hei DL, Braylan RC, et al. Phase Ⅱ study of fludarabine combined with interferon- alpha- za followed by maintenance theraphy with interferon-alpha-za in patients with low-grade non-hodgkin's lyphoma, Am J Clin Oncol,2002,25(4):391-397.
